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Abstract
Background: Following surgical fixation of ankle fractures, the traditional management has included immobilisation
for 6 weeks in a below-knee cast. However, this can lead to disuse atrophy of the affected leg and joint stiffness.
While early rehabilitation from 2 weeks post surgery is viewed as safe, controversy remains regarding its benefits.
We will compare the effectiveness of early motion and directed exercise (EMADE) ankle rehabilitation, against usual
care, i.e. 6 weeks’ immobilisation in a below-knee cast.
Method/design: We have designed a pragmatic randomised controlled trial (p-RCT) to compare the EMADE
intervention against usual care. We will recruit 144 independently living adult participants, absent of tissue-healing
comorbidities, who have undergone surgical stabilisation of isolated Weber B ankle fractures. The EMADE intervention
consists of a non-weight-bearing progressive home exercise programme, complemented with manual therapy and
education. Usual care consists of immobilisation in a non-weight-bearing below-knee cast. The intervention period is
between week 2 and week 6 post surgery. The primary outcome is the Olerud and Molander Ankle Score (OMAS)
patient-reported outcome measure (PROM) at 12 weeks post surgery. Secondary PROMs include the EQ-5D-5 L
questionnaire, return to work and return to driving, with objective outcomes including ankle range of motion.
Analysis will be on an intention-to-treat basis. An economic evaluation will be included.
Discussion: The EMADE intervention is a package of care designed to address the detrimental effects of disuse atrophy
and joint stiffness. An advantage of the OMAS is the potential of meta-analysis with other designs. Within the economic
evaluation, the cost-utility analysis, may be used by commissioners, while the use of patient-relevant outcomes, such
as return to work and driving, will ensure that the study remains pertinent to patients and their families. As it is being
conducted in the clinical environment, this p-RCT has high external validity. Accordingly, if significant clinical benefits and
cost-effectiveness are demonstrated, EMADE should become a worthwhile treatment option. A larger-scale, multicentre
trial may be required to influence national guidelines.
Trial registration: ISRCTN, ID: ISRCTN11212729. Registered retrospectively on 20 March 2017.
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Background
Background and rationale
Ankle fractures are extremely common, accounting for
over 20% of all lower-limb fractures [1] . The AO
(Arbeitsgemeinschaft für Osteosynthesefragen) system of
open reduction and internal fixation (ORIF) technique,
has become the accepted treatment for unstable ankle
fractures [2]. The traditional post-surgery management
has been based on 6 weeks’ non-weight-bearing, with
the ankle immobilised in a below-knee cast.
Detrimental sequelae of this traditional regimen are a
combination of joint stiffness, reduced range of motion
(ROM), pain, reduced circulation, oedema and muscle
atrophy [3–6]. This presentation has been termed ‘fracture
disease’ [2, 7, 8] and ‘cast disease’ [7, 9–12]; the term ‘cast
disease’ is used through the remainder of this protocol.
Attempts to address cast disease can necessitate extended
rehabilitation, but even so, not all patients obtain the
desired recovery [13]. The necessity of delaying rehabilita-
tion for 6 weeks is being increasingly questioned.
Systematic reviews of previous randomised control trials
(RCTs) conclude that early rehabilitation is safe, citing no
statistical difference between early rehabilitation and
control groups in terms of fixation failure, delayed and
non-union and rates of infections. [13–20]. An exception
has been where rehabilitation was started immediately after
surgery [21], yielding an unacceptable wound infection rate
of 66%, in comparison to 16% in the control group. In
contrast, delaying rehabilitation until at least 10 days post
surgery resulted in a wound infection rate of just 9% [22].
While timing appears to be the single biggest risk factor
for iatrogenic wound infections, the reviews identify ambi-
guity surrounding the evidence supporting effectiveness of
early rehabilitation due to risk of methodological bias. For
example, underpowered sample sizes and inadequacies in
reporting of interventions and results [13–20]. The
Cochrane reviewers concluded that while early rehabilita-
tion is mostly safe, there is only ‘limited evidence’ on its
effectiveness [13].
Early interventions can be classed broadly as early
weight-bearing, early exercises or a combination of both.
While NICE [23] recommend further research on early
weight-bearing, the impact of early exercise remains an
important and under-investigated regimen. Where there
has been a focus on exercise as the intervention, it has
mostly been limited to range of motion. A comprehensive
training programme [24] has shown some benefit over a
minimal programme, while in contrast, no supporting
evidence was identified by Moseley et al. [4] for the
addition of stretches and no supporting evidence for the
addition of manual therapy by Lin et al. [25]. However,
interventions for these studies commenced after the
6-week period, by which time cast disease would have
been established.
We propose that an effective way to address the multi-
factorial condition of cast disease is the application of a
multifactorial physiotherapy intervention. Developed
through expert consensus this intervention is based on
early motion and directed exercises (EMADE). To deter-
mine if the EMADE intervention is effective, it is being
assessed against the current usual care for this condition.
The EMADE protocol is presented in accordance with
Standard Protocol Items: Recommendations for Inter-
ventional Trials (SPIRIT) and Template for Intervention
Description and Replication (TIDieR) guidelines (see
Additional files 1 and 2, respectively).
Methods/design
Aim
We aim to establish if, for Weber B ankle fracture patients
who have undergone open reduction and internal fixation,
whether the EMADE intervention is more effective in re-
ducing symptoms and restoring function than usual care.
Primary objective
The primary objective of this study is to test the hypoth-
esis that the early motion and directed exercise (EMADE)
physiotherapy intervention, applied in the clinical setting,
will perform better than usual care at 12 weeks following
operative fixation for Weber B fracture as measured by
the Olerud and Molander Score (OMAS) [26].
Secondary objectives include
1. A key secondary objective is to determine whether,
in this patient group, EMADE will perform better
than usual care in the short term (12 weeks post
surgery) as measured by the EQ-5D-5 L quality of
life measure and the Ankle-Fracture Outcome of
Rehabilitation Measure (A-FORM)
2. To determine whether, in this patient group,
EMADE will perform better than usual care, in
the medium- and long-term (24 and 52 weeks post
surgery, respectively), as measured by the OMAS,
EQ-5D-5 L and A-FORM
3. To explore the cost-effectiveness of EMADE
Trial design and study setting
This is a prospective, pragmatic randomised controlled
trial (p-RCT) of superiority design, with participants allo-
cated in a 1:1 ratio to either of two parallel groups. The
trial is based in the fracture clinic of the Queen’s Medical
Centre, Nottingham University Hospitals, Nottingham,
UK, with other sites being considered.
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Participants, interventions and outcomes
Recruitment
The clinical care team will identify potential participants
from hospital consultant and theatre lists and notify the
researchers of those patients willing to be approached. A
researcher will approach the potential participant and in-
form them of all aspects of the study and provide a written
information sheet (available via http://www.isrctn.com/
ISRCTN11212729). This states that entry is voluntary and
that they are free to withdraw at any time without effect
on subsequent care. If appropriate, following screening
and following the opportunity to make an informed deci-
sion, written consent will be obtained from those willing
to be recruited to the study. Consent will be re-confirmed
verbally at each stage of the study.
Eligibility
Inclusion criteria
1. Patients with isolated, closed Weber B fractures
(AO44-B1, -B2 or -B3) which are stable following
open reduction and internal fixation. This includes
those requiring syndesmosis stabilisation
2. Patients aged 18 years and over
3. Independently living
4. Capable of independently reading and completing
the study paperwork in English
Exclusion criteria
1. Inability to provide informed consent, or declining
participation
2. Comorbidities: diabetes requiring prescription
drugs, non-healing leg/foot ulcers, oral or
intravenously administered steroid users,
pre-existing ankle arthritis and concurrent or
history of significant ipsilateral or contralateral
lower limb injury/condition, e.g. prosthesis in
lower-limb joints, or neurological disorders
3. At the 2-week clinic visit a patient may be excluded
if, based on individual clinical decision, there is
notable risk that early wound movement will
impede satisfactory healing.
4. Those unable to commit to weekly clinic visits,
if assigned to the EMADE intervention group
Interventions
Pre-operatively and, during the first two post-operative
weeks, participants receive identical care consisting of
admission to hospital and consultant supervised surgery
including management on a standard care pathway.
Participants are discharged home in a cast and reviewed 2
weeks following surgery. All participants undergo x-ray
post surgery and wound inspection following cast removal
during the 2-week review (10 to 19 days post surgery). All
participants are non-weight-bearing throughout the study
until the 6-week point.
The EMADE intervention is a progressive home exer-
cise programme that includes range-of-motion (ROM)
and strengthening exercises, and is conducted by the par-
ticipant up to six times a day. To be able to conduct the
exercises, at the 2-week fracture clinic review, those in the
EMADE intervention group are fitted with a removable
below-knee cast with Velcro retaining straps.
The EMADE programme starts with light intensity and
low daily repetitions, and as the weeks progress, becomes
progressively more intensive and repetitive. For example,
exercises start resistance-free, and are followed by
elastic-exercise-band resistance; while the daily repetitions
start twice daily and build up to six times daily. These pro-
gressions are taught during weekly face-to-face sessions
between the week-2 and week-6 fracture clinic reviews.
During the physiotherapy sessions, participants receive
manual therapy consisting of 5 to 10 min of joint and
soft-tissue manipulation to the ankle complex. Advice and
education is on-going and includes; healing processes,
control of pain and swelling, and expectations of fluctu-
ation of pain and swelling. These sessions take part in the
recruiting hospital, and are provided by an experienced
physiotherapist trained in the application of the EMADE
intervention.
To encourage compliance with the EMADE home
exercise programme, participants are provided with writ-
ten and pictorial exercise sheets. These were developed
through patient input and include diary sheets, although
completion of the diary sheets is neither mandatory nor
used in data collection. Participants are not paid to at-
tend, but a basic travel allowance is offered to attend the
additional sessions for the study, but not for usual NHS
care. Participants in the usual care group are treated in a
below-knee cast and remain non-weight-bearing until
the 6-week point.
From the 6-week review, all study participants receive
the same standard care. This includes removal of cast and,
if appropriate following x-ray, weight-bearing as tolerated
may commence, along with physiotherapy as required.
Protocol deviations will be as per standard care, being
based on individual clinical decisions.
Outcome measures
Primary outcome measure
The primary outcome measure is the Olerud and Molander
Ankle Score (OMAS) [26] reported at 12 weeks following
surgery. The OMAS is a validated ankle-fracture PROM
[27, 28] consisting of nine Likert-styled questions; three
symptom- and six function-focussed questions. It is scored
0–100; poorest to best, respectively, and has been treated as
a continuous scale in the Cochrane ankle fracture review
Matthews et al. Trials  (2018) 19:304 Page 3 of 10
[13] and has been recommended by both Cochrane re-
viewers [13] and NICE [23].
Secondary outcome measures
Secondary outcomes including the OMAS collected at 2 and
6 weeks post surgery, as baseline and end-of-intervention
measures, respectively and at 24 and 52 weeks post surgery,
as medium- and long-term follow-ups. Other secondary out-
comes include: the Ankle-Fracture Outcome of Rehabilita-
tion Measure (A-FORM) [29] and the EQ-5D-5 L [30]
PROMs, which are collected at the same time points as the
OMAS. Other function-focussed outcomes include the Phys-
ical Activity Record Scale (PARS) [31], the Clinical Physical
Activity Questionnaire (CPAQ) [32], the use of walking aids,
return to work and return to driving. X-ray findings and
adverse events are also recorded.
When answering Likert-styled questions within the
PROMs, if a participant is unsure which Likert option to
select, they are advised to select the poorer outcome. This
approach is particularly pertinent at the 2-week and 6-week
time points, when answering function-related questions
such as walking, as post-operative clinical instructions
would have been to remain non-weight-bearing. This is not
an anticipated concern for the primary outcome, being at
12 weeks, nor the subsequent follow-ups.
Objective measures are included at the 2-week and
6-week time points: non-weight-bearing dorsiflexion and
plantar flexion ROM and, ankle (figure-of-8) and calf
(circumference) measures. Participants will be invited to
attend for repeated outcome assessments at 12 weeks, 24
weeks and 52 weeks, with the additions of weight-bearing
dorsiflexion, walking speed, balance and isokinetic
plantar-flexion strength. Those declining will be encour-
aged to complete and return the appropriate PROMs
questionnaires.
Participant timeline
Recruitment and consent may take place from the
in-patient stay until and including the 2-week
post-surgery outpatient review. Only after all baseline
outcome measures are recorded, does randomisation
take place, see Figs. 1 and 2.
The data collection time points (post surgery) are: base-
line at 2 weeks, end of intervention at 6 weeks, and at
three research follow-up time points; 12 weeks and 24
weeks as short- and mid-term follow-ups, respectively,
and at 52 weeks as a long-term follow-up and the trial end
point. For participant’s convenience, the 2-week and
6-week EMADE sessions are combined with the ortho-
paedic 2-week and 6-week reviews. The 12-week, 24-week
and 52-week PROMs data may be collected via either
return post (postage pre-paid), electronically or in person
according to participant choice. Participants undergoing
objective assessment will attend the David Greenfield
Human Physiology Unit, Medical School, University of
Nottingham, UK.
Allocation and Blinding
An online computer service, www.sealedenvelope.com is
used for randomisation. This facility generated the codes
concealed from the research team, on a 1:1 allocation
basis to either group, with random order of permuted
blocks (sizes of 4, 6 and 8). Over the duration of the
trial, there is greater potential that those with syndes-
mosis screw(s) may require further surgery. To mitigate
against risk of allocation imbalance, stratification of this
sub-group will be designed into the randomisation.
Blinding (masking)
It is not possible to blind the participant nor the therapist
from the treatment allocation.
However, to reduce risk of bias, 12-, 24- and 52-week
paper PROMs are completed by participants, concealed
from the researchers and stored in sealed opaque enve-
lopes. A third party, blinded to the intervention group in-
puts the data. The electronic PROMs are web-based, held
by Bristol Online Survey (BOS), www.onlinesurveys.ac.uk.
Via this system at the appropriate time points, participants
are e-mailed a single-use link to their e-PROM.
Sample size, data processing and statistical
methods
Sample size calculations
It was estimated that a total of 120 participants will be
required based on a minimal clinical important difference
of 10 points on the OMAS, with a standard deviation of
19.5, significance level of 5% and powered at 80%.
Allowance for attrition was set initially at 20% but, due to
higher-than-expected dropout rates, this was increased to
30%, yielding a target of 156 to enter the study at
randomisation.
Data processing
PROM data collection is paper based, with participant
number 55 onwards being offered the option of complet-
ing PROMs online. Once paper-based 12-week, 24-week
and 52-week PROMs are completed the participant seals
them in a windowless opaque envelop and returns them
to the researchers (postage pre-paid). These are securely
stored and subsequently opened in batches by an
individual blinded to group allocation, who inputs the
data into a holding database for subsequent transfer into
SPSS for reporting and statistical analysis. For audit
purpose, after inputting each batch, a ‘read-only’ copy is
stored in a separate protected folder. A separate copy is
used for data screening and cleaning, guided by good
practice [33] and may include self-evident corrections
[34] where appropriate. While filters and error alerts will
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reduce inputting errors, 20% of entries will be
cross-checked against the paper PROMs for discrepan-
cies. Data changes will be recorded for blinded adjudica-
tion. For audit purposes a copy of the cleaned and
checked data will also be saved as a ‘read-only’ copy and
stored separately. The design of the e-PROMs does not
permit questions to be left unanswered, mitigating
against problems of incomplete data and once the
participant completes their PROM the original dataset is
locked against further alterations. The system permits
data transfer into SPSS.
The research team and statistician will conduct the
analysis. The statistician will conduct the primary
outcome analysis independently and is blinded to group
allocation. Data and reason for any patient excluded
prior to randomisation will be reported, but not carried
into the main analysis. Descriptive statistics will be pro-
duced, within and between each intervention group(s)
for demographics and outcomes at all data time points.
Continuous data will be summarised as mean and stand-
ard deviation and confidence intervals (CI) (95% CI and
p value threshold ≤ 0.05) for the PROM outcome data.
Median and interquartile ranges will be used where
appropriate statistical assumptions are not met, whereas
categorical data will be presented as frequencies and
proportions and analysed using either chi-square or
Fisher’s exact test as indicated (p value of ≤ 0.05).
Non-parametric tests will be employed where appropri-
ate. Analysis will be conducted on the intention-to-treat
(ITT) basis.
Fig. 1 Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) Figure of enrolment, interventions and assessments. Key:
EMADE early motion and directed exercise, PROMs Patient-reported outcome measures. *Study PROMs: Olerud Molander Ankle Score (OMAS),
Ankle-Fracture Outcome of Rehabilitation Measure (A-FORM), EQ-5D-5 L, work and leisure activities, walking aid use and return to driving.
**Option for patients to attend for Laboratory-based objective measures
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To test the primary outcome measure hypothesis that
the EMADE physiotherapy intervention, as described
will perform better than usual care, the difference in
group means of the primary outcome, OMAS values at
12 weeks post surgery, will be statistically compared.
This will be through applying an independent t test with
significance taken as p value of ≤ 0.05 and the inclusion
of confidence intervals (CI at 95% CI and p value of ≤
0.05 threshold). Where data is not found to be normally
distributed such that parametric tests cannot be utilised,
the non-parametric Mann-Whitney U test will be
employed (p value ≤ 0.05).
There is a lack of consensus in the academic literature
on how to handle missing data [35, 36]. However, based
on the 120 sample size, the following sequential approach
will be applied for the primary outcome:
1. If missing data is 5% or less, conduct analysis based
on complete-case analysis
2. If missing data is greater than 5% and up to 10%:
(a) Conduct analysis based on pairwise
deletion (assuming missing at random
(MAR)) and then
(b) Conduct multiple imputation analysis
(c) If these two analyses yield comparable results,
then it will be assumed that the missing data
has not influenced the outcome of the trial
(d) If the two analyses yield notable differences,
to accommodate for the missing data,
sensitivity analysis will be conducted based
on the statistician’s advice
3. If missing data exceeds 10%, detailed discussions
will be held with the study statistician
Fig. 2 A schematic diagram of the patient’s journey through the early motion and directed exercises (EMADE) ankle study. Key: EMADE early
motion and directed exercise, PROMs patient-reported outcome measures
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Interpretation of secondary outcome and sub-group
analysis will require caution due to risks of type II errors
and, because of where post hoc analysis may demonstrate
association, causation may not be supported. Secondary
analyses will be performed for hypothesis generation. The
difference in group mean scores for the secondary out-
comes; EQ-5D-5 L and A-FORM at 12 weeks post surgery
will be analysed in a similar manner to the primary out-
come. The one-way analysis of covariance (ANCOVA), in-
cluding follow-up time as a covariance, will be applied to
assess these outcomes across the complete study period.
Adjustment for baseline scores, through analysis of
covariance, will be conducted for OMAS, EQ-5D-5 L
and A-FORM and compared with unadjusted scores.
Impact of covariates will be further explored through
regression analysis. Initial analysis for co-variates where
significance is nearly reached (p > 0.10) will be taken for-
ward into a statistical model. Due to the bimodal impact
of age and sex, these will be included in this analysis.
Other exploratory analysis for potential covariates may
include impact of smoking, previous level of physical
activity, type of fracture (AO classification), complexity
of surgical repair and any subsequent removal of metal
work; most notably removal of syndesmosis screw(s) for
which stratification was applied at randomisation.
Analysis will also be conducted using modified ITT by
excluding those participants who attend only one session
or less of EMADE sessions.
Sub-groups will include return to work for those
unable to work due to their ankle fracture at the time of
randomisation, and similarly, return to driving for those
unable to drive due to their ankle fracture at the time of
randomisation. Frequency of complications will be
described but, based on the published literature, it is
anticipated that frequency will be sufficiently low not to
warrant statistical analysis.
Health economics
Health economic evaluations will be conducted from a
societal perspective and from the service commis-
sioner’s perspective. The societal perspective will be
limited to incremental cost-effectiveness ratio (ICER) of
the natural units of; return to work and return to
driving (sub-groups as described earlier). Based on the
EQ-5D-5 L PROM data, a cost-utility analysis (costs
per quality-adjusted life year; QALY) will be performed
from the local commission’s perspective. Sensitivity
analysis will include the variability of the additional
EMADE physiotherapy service costs; for example, £18
to £25 per session (2016 rates) and frequency of
post-6-week physiotherapy sessions. The final methods
for health economic evaluations will be guided by dis-
cussion with a health economist.
Governance
Governance procedures were developed following Good
Clinical Practice (GCP) guidelines (non-CTIMP) [37]
with agreements from the local sponsors and the Ethics
Committee. This includes reporting procedures for ad-
verse and serious adverse events. The governance proce-
dures for this trial has been independently audited by
the Quality Assurance and Good Clinical Practice Audit
Office, Nottingham Health Science Partnership, with a
favourable outcome.
Due to the size of the trial it was considered unneces-
sary to form a data monitoring committee. This study will
comply with the requirements of the UK Data Protection
Act 1998 with regards to the collection, storage, process-
ing and disclosure of personal information and will uphold
the Act’s core principles. Access to collated participant
data will be restricted to the research study staff. Alloca-
tion of a unique code to each participant will help to en-
sure confidentiality and anonymity. These identifiers will
be used in all data, study material and reporting. Published
results will not contain any personal data that could allow
identification of individual participants. All electronic data
will be stored on host NHS and University computers,
with limited access under username and password protec-
tion system, as per host NHS and University ICT policies.
Paper-based data will be stored in a locked filing cabinet
in a key-coded room.
Ethics approval and amendments
NRES Committee East Midlands – Nottingham 2,
reviewed and approved this study on 4 November 2014
(14/EM/1213). The Ethics Committee and sponsors have
been informed of important protocol changes and
events. Amendments have focussed on an embedded
study, which has subsequently been removed from the
trial; only two participants were recruited to this embed-
ded study and both participants withdrew from the trial
during their in-patient stay and did not reach random-
isation. Other amendments include: (1) expanding the
recruitment period from the in-patient period, up to and
including the 2-week clinical visit and (2) reducing the
burden on the participant by decreasing the number of
PROMs and permitting PROM completion online. The
time point of randomisation, the intervention, and the
primary and core outcome measures, have all remained
unchanged since the start of recruitment.
Dissemination
Routes of dissemination will include:
1. Medical and associated, conferences, meetings and
journals
2. Patient participation seminars and meetings, such
as those organised by Arthritis Research UK
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3. Further data-sharing plans for the current study are
unknown and will be made available at a later date
Decisions on authorship will be directed by guide-
lines from International Committee of Medical Jour-
nal Editors [38].
Discussion
The aim of this trial is to determine if EMADE is more
effective than usual care in reducing symptoms and restor-
ing function in those who have undergone open reduction
and internal fixation following a Weber B ankle fracture.
While EMADE does not contain novel modalities, what is
distinctive for this trial is EMADE’s early clinical applica-
tion of a progressive ankle rehabilitation programme,
being at 2 weeks post ankle surgery versus the traditional
of starting after 6 weeks of immobilisation.
We do not anticipate significant bias from known con-
founders, such as age and sex, and unknown confounders,
due to the limiting effect on bias from random allocation.
However, as a pragmatic study, there is no control nor
influence over the quality and volume of care, including
physiotherapy, after the end of the intervention at 6 weeks
post surgery.
While compliance with the EMADE home exercise
programme will be encouraged through the weekly
face-to-face reviews and the written and pictorial exercise
sheets, compliance will still be a potential confounder.
However, as a pragmatic trial, this level of encouragement
and supervision was felt to be appropriate, as it reflects
current physiotherapy clinical practice.
It may be argued that starting physiotherapy early with
EMADE will reduce the number of sessions subsequently
required and, thus, the overall number of sessions may
not be significantly different from usual care. However,
while this remains unproven it is pertinent to assume that
EMADE is more expensive (approximately £54 to £75)
and, therefore a cost-utility analysis in QALYs is required
from the commissioner’s perspective to determine if
EMADE is value for money. Also, while QALY units will
be valued by commissioners, the use of natural units;
return to driving and return to work will be tangible to
patients and their families.
As this intervention requires no specialist equipment, it
is suitable for provision in both primary and secondary
care-based physiotherapy departments and, therefore, has
potential for broad clinical impact. The trial design limits
bias where possible, including during the collection, pro-
cessing and analysis of PROM data. Objective outcomes
will be recorded unblinded; however, being secondary
outcomes and analysed separately from the PROM data,
the potential impact of bias from objective data will have
limited impact on the overall quality of the study.
The primary objective of this study is to test whether
the EMADE intervention is effective in the clinical set-
ting. Therefore, it is appropriate to assess effectiveness
of EMADE against usual care in the clinical setting,
through a p-RCT. If significant clinical benefits and
cost-effectiveness are demonstrated, EMADE should be-
come a viable treatment option. A larger-scale, multicen-
tre trial may be required to influence national guidelines.
Trial status
At the time of manuscript submission 111 participants
had joined the trial.
Protocol version
Version 2.2, 18 April 2017. First recruit June 2015, last
expected mid 2018.
Additional files
Additional file 1: Early motion and directed exercises (EMADE) Standard
Protocol Items: Recommendations for Interventional Trials (SPIRIT)
Checklist. (DOCX 53 kb)
Additional file 2: Early motion and directed exercises (EMADE) and
Template for Intervention Description and Replication (TIDieR) Checklist.
(DOCX 30 kb)
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